Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lille
Clinical trial register · France

Clinical Trials in Lille, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 2821 Lyon 1392 Bordeaux 1389 Marseille 1285 Lille 1282
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Lille138 Janssen Research & Development, LLC43 Hoffmann-La Roche40 AstraZeneca36 Assistance Publique - Hôpitaux de Paris34
Site location
Paris2821 Lyon1392 Bordeaux1389 Marseille1285 Lille1282
All 804 locations
Target enrolment
to

Trials with a site in Lille

1282 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
University Hospital, Limoges
Not applicable
244
Bordeaux, Brest, Bron, Dijon, Grenoble, Lille, Limoges, Marseille
2024-05-06
Active, closed
Centre Hospitalier Universitaire de Nice
Phase 2
128
Nice, Paris, Bordeaux, Lille, Lyon
2024-05-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
473
Bordeaux, Lyon, Caen, Toulouse, Lille, Rennes, Poitiers, Paris
2024-05-03
Active, closed
Hoffmann-La Roche
Phase 2
256
Bron, Lille, Marseille, Paris, Rouen, Saint-Herblain, Strasbourg, Toulouse
2024-05-02
By invitation
University Hospital, Caen
Observational
200
Angers, Caen, Grenoble, Lille, Lyon, Metz, Montpellier, Nîmes
2024-05-01
Recruiting
Enhanced Valves Interventions and Safe AI Generated End Results
NCT07213531Heart Valve Disease, TAVI, M-TEER, TTVI
Montreal Heart Institute
Observational
21,000
Bourdeaux, Lille, Marseille, Paris, Rennes, Toulouse
2024-05-01
Not yet open
FH ORTHO SAS Knee Observatory
NCT06207968Knee Surgery
FH ORTHO
Observational
487
Beaumont, Belfort, Boujan-sur-Libron, Écully, Garches, Lille, Saint-Grégoire, Saint-Nazaire
2024-05
Active, closed
Erasca, Inc.
Phase 3
78
Bordeaux, Dijon, Le Mans, Lille, Lyon, Marseille, Paris, Villejuif
2024-04-29
Recruiting
CSL Behring
Phase 2/3
3,110
Amiens, Aura, Brest, Caen, Compiègne, Grabels, Lille, Limoges
2024-04-27
Active, closed
Amgen
Phase 3
111
Bordeaux, Lille, Paris
2024-04-22
Recruiting
Janssen Research & Development, LLC
Phase 1/2
287
Avignon, Lille, Nantes, Paris, Villejuif
2024-04-22
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Lille, Limoges, Lyon, Marseille, Paris, Quint-Fonsegrives, Rennes, Toulouse
2024-04-18
Recruiting
University Hospital, Lille
Observational
320
Lille
2024-04-18
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Amiens, Clermont-Ferrand, Lille, Marseille, Nantes, Paris
2024-04-17
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Besançon, Bron, Clermont-Ferrand, Gonesse, Lille, Montpellier, Nancy, Nantes
2024-04-16
By invitation
Intellia Therapeutics
Observational
100
Grenoble, Lille
2024-04-12
Active, closed
University Hospital, Lille
Not applicable
86
Lille
2024-04-11
Recruiting
University Hospital, Rouen
Not applicable
131
Amiens, Angers, Besançon, Bobigny, Bondy, Bordeaux, Clermont-Ferrand, Lille
2024-04-10
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Lille, Limoges, Marseille, Paris, Quint-Fonsegrives, Rennes, Suresnes
2024-04-09
Recruiting
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
NCT04786587Alcohol Drinking, Pregnancy
University Hospital, Lille
Observational
2,425
Lille
2024-04-08
Active, closed
Shape Memory Medical, Inc.
Not applicable
180
Lille, Paris
2024-04-05
Recruiting
UNICANCER
Phase 2
420
Saint-Denis, Avignon, Dijon, Lille, Marseille, Nice, Nîmes, Paris
2024-04-03
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Toulouse, Angers, Lille, Paris, Villejuif
2024-03-28
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
120
Lille, Paris
2024-03-28
Recruiting
French Innovative Leukemia Organisation
Phase 2
40
Amiens, Angers, Bayonne, Clermont-Ferrand, Grenoble, Lille, Limoges, Lyon
2024-03-21
Active, closed
GlaxoSmithKline
Phase 4
336
Brest, Cannes, Lille, Lyon, Strasbourg, Toulouse
2024-03-20
Recruiting
Verastem, Inc.
Phase 3
270
Besançon, Dijon, Lille, Lyon, Paris
2024-03-18
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
411
Amiens, Clermont-Ferrand, Lille, Lyon, Montpellier, Nice, Paris, Saint-Herblain
2024-03-15
Recruiting
AstraZeneca
Phase 3
100
Bordeaux, Bron, Le Kremlin-Bicêtre, Lille, Toulouse
2024-03-14
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Strasbourg, Dijon, Toulouse, Montpellier, Tours, Nancy, Lille, Lyon
2024-03-14
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Amiens, Lille, Paris
2024-03-13
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,350
Amiens, Angers, Bordeaux, Clichy, Lille, Limoges, Lyon, Montpellier
2024-03-13
Recruiting
A Prospective Trial in Patients With Crohn's Disease in Remission and Having Irritable Bowel Syndrome-like Symptoms
NCT06104631Irritable Bowel Syndrome-like Symptoms, Crohn Disease Remission
Biokuris s.a.
Not applicable
50
Lille
2024-03-12
Recruiting
Centre Francois Baclesse
Phase 2
52
Caen, Lille
2024-03-11
Active, closed
AbbVie
Phase 1
152
Lille, Lyon, Villejuif
2024-03-08
Active, closed
Eli Lilly and Company
Phase 3
17,300
Bobigny, Bron, Chambray-lès-Tours, Compiègne, Dijon, Le Coudray, Lille, Lyon
2024-03-05
Active, closed
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
NCT06238479Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
490
Lille, Lyon, Marseille, Strasbourg, Villejuif
2024-03-05
Recruiting
Changes in Attentional Control After a Focal Seizure.
NCT06466681Temporal Lobe Epilepsy, Frontal Lobe Epilepsy, Others Subtypes
University Hospital, Lille
Observational
100
Lille
2024-03-04
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Angers, Bordeaux, Lille, Nice, Paris
2024-03-04
Active, closed
AstraZeneca
Phase 3
594
Besançon, Brest, Lille, Lyon, Nantes
2024-03-04
Recruiting
PTC Therapeutics
Phase 3
56
Lille, Paris, Tours
2024-03-04
Active, closed
Sanofi
Phase 3
464
Bordeaux, Clermont-Ferrand, Créteil, Lille, Paris, Rouen, Saint-Pierre
2024-02-29
Recruiting
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
NCT05500391Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors, Ovarian Germ Cell Tumor
Centre Oscar Lambret
Phase 2
88
Amiens, Caen, Lille
2024-02-28
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
740
Bordeaux, Dijon, Lille, Lyon, Marseille, Nantes, Toulouse, Vandœuvre-lès-Nancy
2024-02-26
Active, closed
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
NCT06239467Advanced Cancer, Breast Cancer, Advanced Solid Tumors, PI3K Gene Mutation
DrugsAtirmociclib·Tucatinib·Ribociclib·Fulvestrant
OnKure, Inc.
Phase 1
200
Dijon, Lille, Lyon, Nice, Pierre-Bénite, Villejuif
2024-02-26
Recruiting
Dumping Syndrome and Esophageal Atresia
NCT04522193Oesophageal Atresia, Dumping Syndrome
University Hospital, Lille
Not applicable
15
Lille
2024-02-23
Recruiting
Radiofrequency Ablation vs Doppler-guided Haemorrhoidal Artery Ligation in the Treatment of Haemorrhoidal Disease
NCT06170736Haemorrhoids, Internal Haemorrhoids, Grade II/III Haemorrhoids
Centre Hospitalier Departemental Vendee
Not applicable
168
Amiens, Angers, Bordeaux, Brest, Écully, La Roche-sur-Yon, Lille, Limoges
2024-02-21
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Besançon, Cholet, Créteil, Lille, Marseille, Montpellier, Paris, Pessac
2024-02-21
Active, closed
Hemerion Therapeutics
Phase 1/2
12
Lille
2024-02-20
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Lille, Marseille, Nice, Paris, Villefranche-sur-Saône
2024-02-20
Recruiting
Italfarmaco
Phase 3
138
Lille, Marseille, Paris
2024-02-19
Recruiting
Lille Catholic University
Not applicable
100
Lille, Lomme
2024-02-19
Recruiting
HRD Tests for Ovarian cancER
NCT06152731Ovarian Cancer
Centre Francois Baclesse
Phase 2
88
Amiens, Caen, Lille, Rouen
2024-02-15
Recruiting
University Hospital, Lille
Not applicable
40
Lille
2024-02-14
Recruiting
argenx
Observational
100
Bordeaux, Bron, Lille, Marseille, Paris, Strasbourg
2024-02-13
Recruiting
Amryt Pharma
Phase 4
12
Lille, Paris, Pierre-Bénite
2024-02-08
Recruiting
Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients
NCT06038162Venoarterial Extracorporeal Membrane Oxygenation, Renal Replacement Therapy, Acute Kidney Injury
Hospices Civils de Lyon
Not applicable
158
Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Lille, Lyon, Montpellier, Paris
2024-02-07
Recruiting
Effect of Attentional Therapy on Post-traumatic Stress Disorder
NCT05331534Post Traumatic Stress Disorder
University Hospital, Lille
Not applicable
140
Lille
2024-02-02
Recruiting
University Hospital, Bordeaux
Observational
375
Bordeaux, Bruges, Lille, Lyon, Marseille, Narbonne, Osny, Pessac
2024-02-01
Active, closed
Astellas Gene Therapies
Not applicable
119
Angers, Garches, Lille, Limoges, Marseille, Nantes, Nice, Strasbourg
2024-02-01
Recruiting
Ad scientiam
Not applicable
144
Garches, Grenoble, Lille, Nancy, Nantes, Paris, Strasbourg, Toulouse
2024-01-24
Active, closed
Bayer
Phase 2
13
Lille, Clichy, Villejuif
2024-01-24
Recruiting
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
NCT06137144Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Peripheral T-cell Lymphoma (PTCL)
DrugsAZD3470·Keytruda·Pembrolizumab
AstraZeneca
Phase 1/2
161
Créteil, Dijon, Lille, Pierre-Bénite, Villejuif
2024-01-23
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Lille, Limoges, Lyon, Marseille, Nantes, Paris, Pessac, Strasbourg
2024-01-22
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
89
Besançon, Bordeaux, Brest, Créteil, Lille, Lyon, Marseille, Montpellier
2024-01-22
Recruiting
University Hospital, Toulouse
Not applicable
440
Amiens, Bordeaux, La Tronche, Le Kremlin-Bicêtre, Lille, Lyon, Nancy, Paris
2024-01-19
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Bron, Dijon, Lille, Paris, Toulouse
2024-01-19
Recruiting
University Hospital, Rouen
Not applicable
200
Lille, Nîmes, Rouen
2024-01-18
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
DrugsElironrasib·RMC-9805·Cetuximab·Pemetrexed
Revolution Medicines, Inc.
Phase 1/2
616
Bron, Dijon, Lille, Nantes, Bordeaux, Angers, Boulogne, Caen
2024-01-18
Recruiting
University Hospital, Bordeaux
Not applicable
256
Bayonne, Besançon, Brest, Caen, Clermont-Ferrand, Colombes, La Tronche, Lille
2024-01-15
Recruiting
French Innovative Leukemia Organisation
Phase 2
33
Amiens, Angers, Clamart, Clermont-Ferrand, Créteil, Grenoble, Lille, Limoges
2024-01-13
Recruiting
ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
NCT05787197Metastatic Colorectal Cancer, Circulating Tumor DNA
GERCOR - Multidisciplinary Oncology Cooperative Group
Observational
232
Besançon, Bordeaux, Lille, Lyon, Paris, Pessac, Poitiers, Rouen
2024-01-09
Recruiting
Ryvu Therapeutics SA
Phase 2
98
Grenoble, Le Mans, Lille, Marseille, Nice, Nîmes, Paris, Rouen
2024-01-05
By invitation
Sanofi
Phase 3
90
Créteil, Lille, Nice, Paris
2024-01-03
Recruiting
Michaël RACODON
Not applicable
90
Lille
2024-01-02
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Lille, Strasbourg, Nîmes, Rennes, Clermont-Ferrand, Bayonne, Villejuif, Paris
2023-12-31
Recruiting
Bristol-Myers Squibb
Phase 1/2
460
Bordeaux, Lyon, Lille, Villejuif, Créteil, Montpellier, Paris, Toulouse
2023-12-29
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Marseille, Rennes, Tours, Bordeaux, Pessac, Lille, Rouen, Nantes
2023-12-28
Recruiting
Centre Hospitalier de Bethune
Phase 2
234
Amiens, Arras, Béthune, Charleville-Mézières, Dieppe, Jossigny, Lens, Lille
2023-12-27
Active, closed
Sanofi
Phase 3
943
Créteil, Gonesse, La Tronche, Lille, Nancy, Nice, Orsay, Paris
2023-12-27
Recruiting
Eli Lilly and Company
Phase 3
1,264
Avignon, Bron, Lille, Lyon Cedex08, Nice, Paris, Pessac, Poitiers
2023-12-21
Recruiting
IO Biotech
Phase 2
60
Lille, Paris
2023-12-21
Recruiting
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
Institut Claudius Regaud
Phase 3
510
Angers, Bordeaux, Brest, Caen, Créteil, Dijon, Lille, Limoges
2023-12-20
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Bron, Lille, Paris
2023-12-20
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
149
Poitiers, Lille, Montpellier, Paris, Antony, Villejuif
2023-12-19
Recruiting
Institut Curie
Phase 2
66
Clermont-Ferrand, Amiens, Avignon, Caen, Dijon, Lille, Montpellier, Nantes
2023-12-19
Recruiting
Janssen-Cilag Ltd.
Observational
900
Lille, Marseille, Nantes, Paris, Toulouse, Vandœuvre-lès-Nancy
2023-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Bordeaux, Lyon Cedex08, Strasbourg, Brest, Quint-Fonsegrives, Lille, Suresnes, Clermont-Ferrand
2023-12-18
Recruiting
Centre Hospitalier St Anne
Phase 3
500
Brest, Caen, Clermont-Ferrand, Dijon, Lille, Montpellier, Nancy, Orsay
2023-12-15
Recruiting
Hospices Civils de Lyon
Not applicable
250
Ajaccio, Amiens, Bron, Caen, Dijon, Le Plessis-Robinson, Lille, Lyon
2023-12-15
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Quimper, Rennes, Tours, Bordeaux, Pessac, Poitiers, Lille, Nantes
2023-12-13
Active, closed
Sanofi
Phase 3
1,655
Calais, Colmar, La Tronche, Lille, Nice, Saint-Herblain
2023-12-13
Recruiting
Azathioprine in MOGAD
NCT05349006Central Nervous System Inflammation, MOG-IgG Associated Disease
DrugAzathioprine
Hospices Civils de Lyon
Phase 3
126
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nancy, Nice, Nîmes
2023-12-12
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Angers, Avignon, Besançon, Caen, Clermont-Ferrand, La Rochelle, Lille, Lyon
2023-12-11
Recruiting
Symatese
Not applicable
20
Lille, Toulouse, Paris
2023-12-08
Recruiting
Institut Claudius Regaud
Not applicable
150
Angers, Bordeaux, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille, Lyon
2023-12-07
Active, closed
Groupe Francophone des Myelodysplasies
Phase 1/2
36
Amiens, Angers, Bobigny, Cesson-Sévigné, Épagny, Grenoble, Le Mans, Lille
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Bordeaux, Lyon Cedex08, Chambray-lès-Tours, Plérin, Besançon, Toulouse, Lille, Montpellier
2023-12-06
Recruiting
AstraZeneca
Phase 1/2
226
Lille, Nantes
2023-12-05
Recruiting
Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology
NCT06033183Radiosensitivity, Pediatric Cancer, Radiation Toxicity
DrugBlood sample
Neolys
Not applicable
100
Caen, Lille
2023-12-02
Recruiting
5 Years' Follow-up Assessment of Surgical Repair for ACL Proximal Rupture
NCT06178497ACL - Anterior Cruciate Ligament Deficiency
GCS Ramsay Santé pour l'Enseignement et la Recherche
Observational
150
Lille
2023-12-01
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT06120283Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer
DrugsBGB-43395·Elacestrant·Letrozole·Fulvestrant
BeOne Medicines
Phase 1
433
Bordeaux, Caen, Lille, Marseille, Paris, Rennes, Saint-Herblain, Villejuif
2023-12-01
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
100
Lyon, Lille
2023-12-01
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Observational
144
Lille
2023-12-01
Recruiting
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.
NCT07630545Parkinson's Disease (PD), Mild to Moderate Parkinson's Disease, Early Stage Parkinson's Disease
Mission Therapeutics
Phase 1
106
Lille, Paris, Toulouse
2023-11-30
Recruiting
University Hospital, Lille
Not applicable
300
Lille
2023-11-30
Active, closed
argenx
Observational
413
Angers, Bordeaux, Brest, Bron, Le Kremlin-Bicêtre, Lille, Limoges, Marseille
2023-11-29
Recruiting
Biomarkers for Invasive Mucormycosis
NCT05406037Mucorales Infection, Mucormycosis
University Hospital, Lille
Observational
100
Lille
2023-11-29
Active, closed
424 General Military Hospital
Observational
122
Lille
2023-11-28
Recruiting
Institut Claudius Regaud
Phase 2
48
Bordeaux, Lille, Limoges, Lyon, Montpellier, Paris, Poitiers, Saint-Herblain
2023-11-28
Recruiting
Novartis Pharmaceuticals
Phase 2/3
232
Angers, Bordeaux, Bron, Caen, Dijon, Lille, Marseille, Montpellier
2023-11-24
Recruiting
AstraZeneca
Phase 3
625
Lille, Lyon, Montpellier, Paris, Saint-Herblain, Toulouse, Vandœuvre-lès-Nancy, Villejuif
2023-11-23
Recruiting
Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients
NCT05850130Colorectal Cancer, Liver Cancer, Gastric Cancer, Pancreas Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicable
182
Amiens, Caen, Créteil, Grenoble, Lille, Nîmes, Paris, Saint-Cloud
2023-11-22
Recruiting
University Hospital, Clermont-Ferrand
Not applicable
321
Annecy, Bordeaux, Caen, Clermont-Ferrand, Créteil, Grenoble, Le Puy-en-Velay, Lille
2023-11-17
Active, closed
The PEERLESS II Study
NCT06055920Pulmonary Embolism
Inari Medical
Not applicable
1,200
Lille, Lyon, Marseille
2023-11-17
Recruiting
Institut Pasteur
Not applicable
210
Bordeaux, Colombes, Créteil, Lille, Lyon, Marseille, Nantes, Paris
2023-11-16
Recruiting
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
NCT06128343Adenocarcinoma, Carcinoma, Neoplasms
University Hospital, Toulouse
Observational
1,500
Béthune, Bordeaux, Lille, Lyon, Montpellier, Pau, Toulouse
2023-11-16
Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
NCT06128551Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
DrugsElironrasib·Cetuximab
Revolution Medicines, Inc.
Phase 1/2
534
Angers, Bordeaux, Bron, Lille, Lyon, Montpellier, Nantes, Strasbourg
2023-11-14
Recruiting
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
NCT05658640Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsTrametinib·Cytarabine·Dexamethasone·Cyclophosphamide
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2023-11-14
Recruiting
Fondation Santé des Étudiants de France
Not applicable
220
Lille, Lyon, Montpellier, Nantes, Paris, Saint-Etienne
2023-11-14
Recruiting
University Hospital, Lille
Observational
300
Lille, Amiens, Angers, Besançon, Bordeaux, Bron, Caen, Clermont-Ferrand
2023-11-14
Active, closed
medac GmbH
Phase 2
49
Bordeaux, La Tronche, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2023-11-13
Active, closed
BeOne Medicines
Phase 3
652
Bordeaux, ClermontFerrand, Esseylesnancy, Le Mans, Lille, Lyon, Nantes, Paris
2023-11-11
Recruiting
Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition
NCT06090201Cerebral Microbleeds, Congenital Haemophilia, Congenital Von Willebrand Disease
University Hospital, Lille
Observational
200
Lille
2023-11-10
Active, closed
AstraZeneca
Phase 3
863
Brest, Créteil, Le Mans, Lille, Lyon, Marseille, Montpellier, Paris
2023-11-09
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
346
Amiens, Bordeaux, Créteil, Le Kremlin-Bicêtre, Lille, Montpellier, Nancy, Paris
2023-11-08
Active, closed
TheraSphere With Durvalumab and Tremelimumab for HCC
NCT05063565Hepatocellular Carcinoma
Boston Scientific Corporation
Phase 2
100
Rennes, Clichy, Grenoble, Clermont-Ferrand, Créteil, Lille, Montpellier, Nantes
2023-11-03
Recruiting
Ad scientiam
Not applicable
103
Lille, Marseille, Montpellier, Nice, Paris, Rouen, Strasbourg, Toulouse
2023-11-03
Active, closed
Amgen
Phase 3
633
Poitier, Rennes, Lille
2023-11-02
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA
Phase 1
200
Lille, Poitiers, Nantes, Paris
2023-11-01
Recruiting
MaaT Pharma
Phase 2
387
Angers, Besançon, Caen, La Tronche, Lille, Limoges, Marseille, Montpellier
2023-10-31
Recruiting
LeonaBio
Phase 3
600
Avignon, Besançon, Bordeaux, Caen, Le Mans, Lille, Lyon, Marseille
2023-10-31
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
170
Dijon, Bourdeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2023-10-27
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Angers, Brest, Dijon, Le Kremlin-Bicêtre, Le Mans, Lille, Paris, Saint-Priest-en-Jarez
2023-10-27
Recruiting
Orion Corporation, Orion Pharma
Phase 1/2
315
Bordeaux, Lille, Villejuif
2023-10-26
Active, closed
AstraZeneca
Phase 3
895
Angers, Avignon, Bayonne, Bordeaux, Caen, Lille, Limoges, Marseille
2023-10-24
Recruiting
Rennes University Hospital
Not applicable
150
Bordeaux, Caen, Clermont-Ferrand, Lille, Lyon, Nantes, Paris, Rennes
2023-10-23
Recruiting
Hoffmann-La Roche
Phase 3
182
Lille, Montpellier, Nantes, Paris
2023-10-22
Active, closed
Centre Hospitalier St Anne
Not applicable
90
Lille, Paris, Rouen
2023-10-18
Active, closed
Genentech, Inc.
Phase 2
260
Lille, Lyon, Marseille, Vandœuvre-lès-Nancy, Villejuif
2023-10-18
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
387
Angers, Bayonne, Bordeaux, Brest, Clermont-Ferrand, Grenoble, Lille, Limoges
2023-10-17
Active, closed
Celgene
Phase 3
79
Pessac, Marseille, Lille, Nantes, Pierre-Bénite, Créteil, Villejuif, Poitiers
2023-10-16
Active, closed
iVascular S.L.U.
Phase 3
2,312
Lille, Massy, Quincy-sous-Sénart, Toulouse
2023-10-13
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
1,132
Amiens, Besançon, Bordeaux, Brest, Clermont-Ferrand, Grenoble, Lille, Marseille
2023-10-12
Active, closed
Stichting European Myeloma Network
Phase 3
759
Lille, Lyon, Nantes, Poitiers, Saint-Louis, Toulouse
2023-10-10
Recruiting
Montefiore Medical Center
Observational
800
Toulouse, Lille, Bordeaux
2023-10-05
Active, closed
AstraZeneca
Phase 3
5,511
Angers, Bordeaux, Caen, Clermont-Ferrand, Dijon, Epagny Metz-Tessy, Lille, Lyon
2023-10-05
Active, closed
Groupe Francophone des Myelodysplasies
Phase 2
44
Amiens, Angers, Bobigny, Cesson-Sévigné, Grenoble, Lille, Limoges, Mont-de-Marsan
2023-10-04
Recruiting
University Hospital, Lille
Phase 1/2
35
Lille
2023-09-29
Recruiting
University Hospital, Toulouse
Not applicable
100
Amiens, Caen, Dijon, Epagny Metz- Tessy, Lille, Lyon, Montpellier, Paris
2023-09-28
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 1/2
94
Lille, Paris
2023-09-28
Recruiting
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Observational
210
Amiens, Bordeaux, Boulogne-Billancourt, Clermont-Ferrand, Colombes, Lille, Limoges, Marseille
2023-09-28
Recruiting
NAC- NAFLD And Cushing
NCT05881005Cushing Syndrome, Fatty Liver Disease
University Hospital, Angers
Not applicable
100
Angers, Bordeaux, Brest, Grenoble, Lille, Nantes, Vandœuvre-lès-Nancy
2023-09-28
Active, closed
Ad scientiam
Not applicable
336
Lille, Lomme, Marseille, Nice, Rouen
2023-09-22
Active, closed
AbbVie
Phase 2
130
Pessac, Montpellier, La Tronche, Lille, Villejuif, Clichy
2023-09-21
Active, closed
PharmaMar
Phase 3
469
Lyon, Besançon, Angers, Nice, Bordeaux, Lille, Limoges, Marseille
2023-09-21
By invitation
Denali Therapeutics Inc.
Phase 2/3
99
Lille
2023-09-20
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Lille, Lyon, Marseille, Montpellier, Nantes, Pessac, Rennes, Rouen
2023-09-18
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Lyon, Pessac, Lille, Paris, Saint-Cloud, Villejuif
2023-09-18
Recruiting
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
NCT05699005Cardiogenic Shock, Extracorporeal Membrane Oxygenation, Transfusion Related Complication, Anemia
University Hospital, Lille
Phase 1
236
Lille, Amiens, Dijon
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
687
Caen, Lille, Limoges, Marseille, Nantes, Paris, Reims, Valence
2023-09-14
Active, closed
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
NCT05869955Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, Systemic Sclerosis, Rheumatoid Arthritis
DrugsZola-cel·Tocilizumab·Fludarabine·Cyclophosphamide
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
270
Pessac, Montpellier, Lille, Nice, Paris, Rennes
2023-09-13
Recruiting
Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome
NCT03059173Polycystic Ovary Syndrome, Reproductive Medicine
University Hospital, Lille
Phase 3
276
Lille
2023-09-12
Recruiting
Centre Hospitalier St Anne
Not applicable
136
La Tronche, Lille, Saint-Priest-en-Jarez, Paris
2023-09-12
Recruiting
Hoffmann-La Roche
Phase 3
230
Avignon, Bayonne, Bordeaux, Dijon, Lille
2023-09-08
Recruiting
Gilead Sciences
Phase 3
402
Bobigny, Lille, Lyon, Montipellier, Paris, Strasbourg, Vandœuvre-lès-Nancy, Villejuif
2023-09-07
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction
Institut für Pharmakologie und Präventive Medizin
Observational
250
Bordeaux, Clermont-Ferrand, Lille, Lyon, Marseille, Massy, Nantes, Paris
2023-09-05
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Clermont-Ferrand, La Tronche, Lille, Montpellier, Nantes, Paris, Pessac, Rennes
2023-09-01
Recruiting
University Hospital, Rouen
Observational
1,000
Caen, Lille
2023-09-01
Recruiting
Ipsen
Phase 3
276
Clichy, Créteil, Lille, Lyon, Marseille, Nice, Paris, Poitiers
2023-08-31
Recruiting
University Hospital, Lille
Observational
270
Lille
2023-08-22
Recruiting
Centre Hospitalier de Lens
Observational
200
Béthune, Boulogne-sur-Mer, Dijon, Lens, Lille
2023-08-21
Recruiting
French Innovative Leukemia Organisation
Observational
500
Amiens, Angers, Bordeaux, Clermont-Ferrand, Le Mans, Lens, Libourne, Lille
2023-08-11
Active, closed
Institut Claudius Regaud
Phase 2
240
Angers, Bordeaux, Créteil, Grenoble, Lille, Lyon, Marseille, Paris
2023-08-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
735
Lille, Clermont-Ferrand, La Roche-sur-Yon
2023-08-08
Recruiting
Coroflex® ISAR NEO PMCF Study
NCT05698732Coronary Artery Disease (CAD), Ischemic Heart Disease
Fundación EPIC
Observational
3,000
Aix-en-Provence, Ajaccio, Bordeaux, Caen, Colmar, Lille, Paris, Rouen
2023-08-04
Active, closed
Prevention of Alopecia in Patients With Localised Breast Cancer
NCT06011525Chemotherapy-induced Alopecia
Centre Francois Baclesse
Not applicable
196
Caen, Lille, Toulouse
2023-08-03
Recruiting
Centre Leon Berard
Not applicable
166
Nantes, Lyon, Angers, Bordeaux, Chambray-lès-Tours, Clermont-Ferrand, Dijon, Lille
2023-08-03
Recruiting
University Hospital, Toulouse
Phase 3
1,164
Angers, Bordeaux, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille, Montpellier
2023-08-02
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Nice, Marseille, Dijon, Besançon, Bordeaux, Rennes, Lille, Pierre-Bénite
2023-07-19
Active, closed
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
NCT05945823Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer, Esophageal Adenocarcinoma, Esophageal Squamous Cell Cancer, Siewert Type 1 GEJ Cancer
DrugsFutibatinib·Leucovorin·Irinotecan·Adrucil
Taiho Oncology, Inc.
Phase 2
53
Lille, Poitiers
2023-07-13
Recruiting
University Hospital, Lille
Not applicable
124
Amiens, Boulogne-sur-Mer, Caen, Lille, Lomme, Montreuil-sur-Mer, Rouen, Saint-Amand-les-Eaux
2023-07-12
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Nîmes, Lille, Lyon, Grenoble, Paris
2023-07-06
Active, closed
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
NCT06094127Thoracic Aortic Aneurysm, Penetrating Aortic Ulcer
Cook Research Incorporated
Observational
300
Dijon, Le Plessis-Robinson, Lille
2023-07-06
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 3
90
Brest, Grenoble, Lille, Limoges, Lyon, Marseille, Nancy, Nantes
2023-06-29
Active, closed
Swedish Orphan Biovitrum
Observational
165
Nice, Pessac, Suresnes, Grenoble, Nantes, Vandœuvre-lès-Nancy, Lille, La Defense
2023-06-26
Recruiting
Innate Pharma
Phase 2
70
Angers, Caen, Lille, Limoges, Lyon, Marseille, Rennes, Rouen
2023-06-23
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Amiens, Caen, Créteil, La Roche-sur-Yon, Lille, Limoges, Nantes, Paris
2023-06-22
Recruiting
Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma
NCT05561634Basal Cell Carcinoma, Radiotherapy; Complications
DrugVismodegib
University Hospital, Lille
Phase 2
82
Lille
2023-06-20
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
23
Bordeaux, Lille, Lyon, Paris, Villejuif
2023-06-16
Active, closed
Alfasigma S.p.A.
Observational
509
Amiens, Besançon, Clichy, Grenoble, Lille, Montpellier, Nancy, Nantes
2023-06-12
Active, closed
AbbVie
Phase 1
135
Bordeaux, Montpellier, Lille, Nantes, Villejuif, Paris
2023-06-09
Recruiting
Food Frequency Questionnaire to Assess Sodium Intake
NCT05533645Hypertension, Renal Insufficiency
University Hospital, Lille
Not applicable
99
Lille
2023-06-06
Recruiting
RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
NCT05758831Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis
Rennes University Hospital
Phase 3
386
Lyon, Brest, Caen, Cergy-Pontoise, Clermont-Ferrand, Gonesse, Lille, Limoges
2023-06-01
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Pessac, Nantes, Lille, Marseille, Paris
2023-05-31
Active, closed
Amgen
Phase 3
509
Grenoble, Lille, Limoges, Lyon, Marseille, Paris, Pierre-Bénite, Rennes
2023-05-31
Recruiting
European Aortic Data Collection Project
NCT05896397Complex Abdominal Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm, Chronic Aortic Dissection
Cook Research Incorporated
Observational
600
Le Plessis-Robinson, Lille
2023-05-31
Recruiting
Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
NCT04119908Von Willebrand Diseases, Glanzmann Thrombasthenia
DrugBlood sample
University Hospital, Lille
Not applicable
400
Lille
2023-05-24
Recruiting
ENDOMETRIOSIS - MRI
NCT05779462Endometriosis, Mobility Limitation, Magnetic Resonance Imaging, Diagnosis
University Hospital, Lille
Observational
52
Lille
2023-05-23
Recruiting
Pfizer
Phase 2
100
Nice, Strasbourg, Bordeaux, Toulouse, Vandœuvre-lès-Nancy, Lille, Paris, Lyon
2023-05-17
Recruiting
Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context
NCT06083415Puberty, Precocious, Breast, Environmental Exposure
Lille Catholic University
Not applicable
62
Lambersart, Lille
2023-05-15
Recruiting
OPTImal Treatment of Sinus VENOSUS Defect
NCT05865119Sinus Venosus Defect, Congenital Heart Disease, Sinus Venosus Atrial Septum Defect
Centre Chirurgical Marie Lannelongue
Not applicable
60
Bordeaux, Bron, Clermont-Ferrand, Grenoble, Le Plessis-Robinson, Lille, Marseille, Nantes
2023-05-12
Recruiting
Centre Hospitalier Universitaire de Nīmes
Observational
120
La Rochelle, Lille, Paris, Strasbourg
2023-05-11
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Bron, Lille, Paris, Rennes, Strasbourg
2023-05-09
Active, closed
Gilead Sciences
Phase 3
654
Besançon, Bordeaux, Dijon, Lille, Limoges, Loire Atlantique, Lyon, Marseille
2023-05-08
Active, closed
CEN Biotech
Observational
239
Dijon, Lille, Orléans, Saint-Priest-en-Jarez
2023-05-05
Recruiting
University Hospital, Toulouse
Not applicable
296
Amiens, Bordeaux, Clermont-Ferrand, Lille, Nantes, Paris, Saint-Denis, Toulouse
2023-05-02
Recruiting
The Ailliance Post-Market Clinical Study
NCT05856370Spinal Deformity, Spinal Degenerative Disorder, Spinal Fusion Failure, Spinal Trauma
Medtronic Spinal and Biologics
Not applicable
1,000
Dijon, Lille
2023-05-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
600
Angers, Bron, Caen, Chambray-lès-Tours, Dijon, Grenoble, Lille, Montpellier
2023-04-28
Active, closed
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
NCT05626855Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, SMA
DrugApitegromab
Scholar Rock, Inc.
Phase 3
238
Lille, Paris, Toulouse
2023-04-17
Active, closed
Jazz Pharmaceuticals
Observational
158
Amiens, Angers, Bordeaux, Bron, Dijon, Grenoble, Le Kremlin-Bicêtre, Lille
2023-04-17
Recruiting
Institut Curie
Not applicable
50
Tours, Avignon, Bordeaux, Clermont-Ferrand, Grenoble, Lille, Lyon, Montpellier
2023-04-08
Recruiting
Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
NCT05641142Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease
University Hospital, Clermont-Ferrand
Not applicable
100
Angers, Bordeaux, Boulogne-Billancourt, Caen, Clermont-Ferrand, Dijon, Lille, Lyon
2023-04-07
Active, closed
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
NCT05618028Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies, Non-Hodgkin's Lymphoma
AbbVie
Phase 1
78
Lille, Toulouse
2023-04-04
Active, closed
Sanofi
Phase 2
999
Créteil, Lille, Marseille, Nantes, Paris, Pierre-Bénite, Toulouse
2023-04-03
Recruiting
Centre Hospitalier Intercommunal Creteil
Not applicable
180
Brest, Corbeil-Essonnes, Créteil, Lille, Tours
2023-04-01
Recruiting
Fondation Lenval
Not applicable
600
Angers, Aulnay-sous-Bois, Clermont-Ferrand, Colmar, Grenoble, Haguenau, Lille, Lyon
2023-03-31
Recruiting
University Hospital, Lille
Observational
30
Lille
2023-03-30
Recruiting
Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy
NCT05609084Epilepsy, Anomia, Temporal Lobe Epilepsy
Assistance Publique Hopitaux De Marseille
Not applicable
214
Bordeaux, Grenoble, Lille, Lyon, Marseille, Nancy, Paris, Rennes
2023-03-30
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Amiens, Caen, Grenoble, Le Mans, Lille, Montpellier, Nantes, Paris
2023-03-29
Recruiting
University Hospital, Lille
Not applicable
31
Lille
2023-03-28
Active, closed
UNICANCER
Phase 2
100
Aix-en-Provence, Avignon, Bayonne, Caen, Clermont-Ferrand, Créteil, Dijon, Lille
2023-03-24
Recruiting
Blood Screening for Adult Colorectal Cancer
NCT05577143Cancer Colorectal
University Hospital, Lille
Observational
303
Lille
2023-03-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 4
480
Corbeil-Essonnes, Orsay, Clamart, Boulogne, Nantes, Lille, Paris, Meaux
2023-03-22
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
200
Bordeaux, Lille, Lyon, Nice, Paris, Poitiers, Rennes, Saint-Priest-en-Jarez
2023-03-22
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 1/2
26
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nancy, Nantes, Paris
2023-03-15
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
177
Lille, Marseille, Nantes, Nice, Rennes, Toulouse
2023-03-10
Active, closed
Hospices Civils de Lyon
Phase 4
20
Besançon, Dijon, Lille, Lyon, Montpellier, Paris, Reims, Toulouse
2023-03-09
By invitation
Eli Lilly and Company
Phase 3
333
Romans-sur-Isère, Lille, Nantes, Toulouse
2023-03-09
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
14,500
Angers, Bordeaux, Bron, Clamart, Clermont-Ferrand, Créteil, Dijon, Lille
2023-03-06
Recruiting
Cost-utility of Focal HIFU vs Prostatectomy
NCT05710861Prostate Cancer
University Hospital, Bordeaux
Not applicable
346
Besançon, Bordeaux, Colmar, Grenoble, Guilherand-Granges, Lille, Lyon, Marseille
2023-03-06
Active, closed
Bristol-Myers Squibb
Phase 3
579
Toulouse, Chambray-lès-Tours, Lille, Nantes, Villejuif, Amiens, Bayonne, Bordeaux
2023-03-06
Recruiting
Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
NCT05711173Venous Thromboses, Thromboembolic Disease, Neutrophil Extracellular Trap Formation, Clonal Hematopoiesis of Indeterminate Potential
DrugAdditional blood sampling
University Hospital, Bordeaux
Not applicable
150
Bordeaux, Lille, Marseille
2023-03-03
Recruiting
Frequency of SPAD in Adult Patients
NCT05664035Specific Antibody Deficiency, Predominantly Antibody Deficiencies
University Hospital, Lille
Observational
99
Lille
2023-03-01
Recruiting
University Hospital, Rouen
Observational
2,500
Caen, Elbeuf, La Rochelle, Le Havre, Lille, Lomme, Rennes, Rouen
2023-03-01
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Annonay, Bobigny, Grenoble, Le Coudray, Le Havre, Lille, Montpellier, Paris
2023-03-01
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugsTovorafenib·Carboplatin
Day One Biopharmaceuticals, Inc.
Phase 3
418
Lille, Lyon, Marseille, Paris, Villejuif
2023-02-27
Active, closed
Novartis Pharmaceuticals
Phase 1
38
Lille, Paris, Toulouse
2023-02-23
Recruiting
Elsan
Not applicable
450
Caluire-et-Cuire, Libourne, Lille, Lomme, Neuilly-sur-Seine, Nîmes, Paris, Perpignan
2023-02-20
Recruiting
University Hospital, Lille
Observational
750
Lille
2023-02-16
Recruiting
University Hospital, Rouen
Not applicable
80
Bordeaux, Lille, Paris, Rouen
2023-02-15
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Lille, Lyon, Paris, Rennes, Strasbourg
2023-02-14
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Bron, Le Kremlin-Bicêtre, Lille, Nantes
2023-02-13
Active, closed
Kite, A Gilead Company
Phase 3
300
Bordeaux, Cedex Lyon 08, Dijon, Lille, Montpellier, Nice, Paris, Rennes
2023-02-10
By invitation
Novo Nordisk A/S
Observational
400
Bron, Lille, Marseille, Paris, Reims
2023-02-03
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Caen, Chambéry, Le Mans, Lille, Rennes
2023-02-03
Active, closed
Hoffmann-La Roche
Phase 2
301
Angers, Bordeaux, Créteil, Lille, Marseille, Montpellier, Strasbourg, Toulouse
2023-02-03
Active, closed
EDAP TMS S.A.
Not applicable
60
Aix-en-Provence, Angers, Bordeaux, Clermont-Ferrand, Le Kremlin-Bicêtre, Lille, Lyon, Paris
2023-02-03
Active, closed
Mepolizumab and Physical Activity in Severe Asthma
NCT05404763Asthma, Asthma; Eosinophilic
University Hospital, Lille
Observational
62
Lille
2023-02-02
Active, closed
Sanofi
Phase 3
91
Le Kremlin-Bicêtre, Lille, Paris
2023-02-01
Active, closed
Institut de Cancérologie de Lorraine
Not applicable
136
Besançon, Dijon, Lille, Mulhouse, Reims, Vandœuvre-lès-Nancy
2023-01-31
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
60
Nice, Montpellier, Lille
2023-01-31
Recruiting
Women Hypertensive and Young-Renal Denervation
NCT05563337Arterial Hypertension
University Hospital, Bordeaux
Not applicable
80
Bordeaux, Grenoble, Lille, Nantes, Paris, Toulouse
2023-01-31
Recruiting
University Hospital, Lille
Observational
190
Lille
2023-01-30
Recruiting
University Hospital, Lille
Observational
356
Béthune, Boulogne-sur-Mer, Calais, Lens, Lille, Nantes, Roubaix, Rouen
2023-01-30
Recruiting
University Hospital, Rouen
Not applicable
76
Caen, Lille, Rouen
2023-01-25
Recruiting
Centre Hospitalier Universitaire de Nīmes
Observational
150
Boulogne-sur-Mer, Bron, Corbeil-Essonnes, Grenoble, Le Creusot, Le Kremlin-Bicêtre, Lens, Lille
2023-01-23
Active, closed
argenx
Phase 2
51
Bordeaux, Lille, Nice, Paris
2023-01-18
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Dijon, Besançon, Bordeaux, Toulouse, Lille, Montpellier, La Tronche, Caen
2023-01-16
Recruiting
Shionogi
Phase 1/2
24
Caen, Clamart, Lille, Paris
2023-01-04
By invitation
BioMarin Pharmaceutical
Observational
172
Lille, Marseille
2023-01-01
Active, closed
Exelixis
Phase 3
317
Angers, Caen, Clermont-Ferrand, Créteil, Le Mans, Lille, Lyon, Marseille
2023-01-01
Active, closed
Novartis Pharmaceuticals
Phase 3
90
Créteil, Lille, Nantes, Nice
2022-12-30
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Amiens, Lille, Paris, Pessac
2022-12-29
Active, closed
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
NCT05024773Bladder Carcinoma in Situ (CIS)
Fidia Farmaceutici s.p.a.
Phase 3
130
Bordeaux, Clermont-Ferrand, Lille, Marseille, Paris, Poitiers
2022-12-29
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Lille, Marseille, Nantes, Paris, Rennes, Strasbourg, Toulouse, Villeurbanne
2022-12-23
Recruiting
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
NCT04935684Acute Leukemia in Remission, Myelodysplastic Syndromes, Myeloproliferative Syndrome, Hodgkin Lymphoma
DrugFecal Microbiota Transplantation
University Hospital, Clermont-Ferrand
Phase 2
150
Amiens, Angers, Besançon, Clermont-Ferrand, Grenoble, Lille, Limoges, Lyon
2022-12-20
Recruiting
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
NCT05752552Adult Solid Tumor, Advanced Solid Tumor, Refractory Tumor, Non-small Cell Lung Cancer
DeuterOncology
Phase 1
55
Bordeaux, Lille, Lyon, Marseille, Nice, Rennes, Villejuif
2022-12-20
Recruiting
H. Lundbeck A/S
Phase 1/2
42
Angers, Lille, Paris, Strasbourg
2022-12-19
Recruiting
Canadian Cancer Trials Group
Phase 2
393
Lyon, Villejuif, Lille, Toulouse, Paris
2022-12-19
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Amiens, Besançon, Bordeaux, Grenoble, Lille, Lyon, Marseille, Montpellier
2022-12-15
Active, closed
Bristol-Myers Squibb
Phase 2/3
230
Pessac, Tours, Angers, Lille, Villejuif, Paris
2022-12-14
Active, closed
Amgen
Phase 3
7,297
Besançon, Bron, Chambray-lès-Tours, Compiègne, Dijon, Lille, Marseille, Montpellier
2022-12-14
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
Lille, Marseille, Saint-Herblain, Strasbourg
2022-12-13
Recruiting
Pharming Technologies B.V.
Phase 2
180
Angers, Bordeaux, Lille, Nantes, Nice, Paris, Strasbourg
2022-12-13
Active, closed
Carmat SAS
Not applicable
104
Bron, Dijon, Le Plessis-Robinson, Lille, Montpellier, Nantes, Paris, Rennes
2022-12-12
Active, closed
Institut Curie
Not applicable
79
Clichy, Créteil, Lille, Marseille, Reims, Saint-Cloud, Villejuif
2022-12-12
Recruiting
University Hospital, Bordeaux
Not applicable
250
Bordeaux, Lille, Limoges, Poitiers
2022-12-06
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 2
20
Amiens, Angers, Brest, Bron, Clermont-Ferrand, Dijon, Lille, Nîmes
2022-11-28
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 4
41
Agen, Brest, Bordeaux, Boulogne-Billancourt, Créteil, Dijon, Lille, Marseille
2022-11-25
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Bron, Créteil, Lille, Marseille, Montpellier, Nantes, Nice, Paris
2022-11-23
Active, closed
Novartis Pharmaceuticals
Phase 3
568
Bordeaux, Caen, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes, Nice
2022-11-21
Recruiting
Centre Hospitalier Intercommunal Creteil
Phase 3
230
Bordeaux, Créteil, Le Kremlin-Bicêtre, Lille, Lyon, Marseille, Nancy, Nantes
2022-11-21
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Garches, Lille, Marseille, Nice, Paris, Strasbourg
2022-11-21
Active, closed
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
NCT05407324Amyotrophic Lateral Sclerosis
Corcept Therapeutics
Phase 2
279
Bron, Lille, Limoges, Marseille, Montpellier, Nice, Paris, Tours
2022-11-15
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Bordeaux, Bron, Créteil, Lille, Montpellier, Nice, Paris, Pierre-Bénite
2022-11-08
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2
87
Marseille, Angers, Lille, Paris
2022-11-07
Recruiting
Perinatal Covid-19 Infection, NO Pathway, and Minipuberty
NCT04952870Newborn, Infant, Disease, Neurodevelopmental Disorders
University Hospital, Lille
Observational
180
Lille
2022-11-03
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
80
Lille, Paris, Pessac, Pierre-Bénite
2022-10-28
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
250
Lille, Paris, Rouen
2022-10-26
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Créteil, Lille, Lyon, Nantes, Paris, Pessac, Poitiers, Rennes
2022-10-25
Recruiting
The CATALINA Study
NCT05008081Chronic Obstructive Pulmonary Disease Exacerbation
Wim Janssens
Observational
1,000
Lille, Paris
2022-10-25
Active, closed
Almirall, S.A.
Phase 4
447
Lille, Marseille, Nice, Paris, Rouen, Saint-Priest-en-Jarez
2022-10-24
Recruiting
Centre Hospitalier Arras
Observational
241
Arras, Douai, Lens, Lille
2022-10-24
Recruiting
University Hospital, Lille
Not applicable
396
Lille
2022-10-13
Active, closed
Bayer
Phase 1
129
Lille, Bordeaux, Saint-Herblain, Villejuif
2022-10-11
Recruiting
University Hospital, Lille
Observational
50
Lille
2022-10-10
Recruiting
University Hospital, Lille
Observational
100
Lille
2022-10-07
Recruiting
EMD Serono Research & Development Institute, Inc.
Observational
700
Cholet, Lille, Lorient, Lyon, Paris, Rennes, Toulouse
2022-10-04
Recruiting
University Hospital, Bordeaux
Not applicable
336
Aix-en-Provence, Angers, Bordeaux, Créteil, Lille, Limoges, Marseille, Nice
2022-09-29
Recruiting
INSIGHTFUL-FFR Clinical Trial
NCT05437900Coronary Artery Disease, Acute Coronary Syndrome
CoreAalst BV
Phase 4
2,500
Lille, Lyon, Paris
2022-09-22
Active, closed
Kite, A Gilead Company
Phase 3
231
Créteil, Dijon, Lille, Marseille, Montpellier, Paris, Pessac, Pierre-Bénite
2022-09-22
Recruiting
Celgene
Phase 3
810
Pessac, Lyon Cedex08, Lille, Clermont-Ferrand, Limoges, Nantes, Nîmes, Strasbourg
2022-09-20
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Amiens, Colombes, Créteil, Grenoble, La Roche-sur-Yon, Lille, Marseille, Montpellier
2022-09-19
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
DrugElironrasib
Revolution Medicines, Inc.
Phase 1
222
Angers, Bordeaux, Clermont-Ferrand, Lille, Lyon, Nantes, Strasbourg
2022-09-19
Recruiting
Centre Oscar Lambret
Phase 1/2
28
Amiens, Besançon, Bordeaux, Grenoble, Lille, Lyon, Marseille, Montpellier
2022-09-14
Active, closed
Biogen
Phase 2/3
450
Nice, Marseille, Caen, Besançon, Toulouse, Antony, Montpellier, Lille
2022-09-13
Recruiting
University Hospital, Lille
Observational
417
Lille
2022-09-09
Active, closed
Imagery as Biomarker of Gout
NCT05434858Hyperuricemia
Lille Catholic University
Not applicable
21
Lille
2022-09-09
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Bordeaux, Lille, Marseille, Montpellier, Nantes, Paris, Poitiers, Toulouse
2022-09-08
Active, closed
Genetics of Ventriculo-arterial Discordance
NCT05330338Heart Defects, Congenital
Nantes University Hospital
Not applicable
600
Marseille, Rennes, Bordeaux, Toulouse, Lille, Le Plessis-Robinson, Nantes, Saint-Herblain
2022-09-07
Recruiting
Centre Leon Berard
Phase 2
90
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lille, Limoges, Lyon, Marseille
2022-09-06
Recruiting
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
NCT05288842Alzheimer Disease, Frontotemporal Dementia
DrugsLumbar puncture·Blood sample
University Hospital, Lille
Observational
102
Lille
2022-09-06
By invitation
Ottawa Heart Institute Research Corporation
Observational
3,500
Amiens, Créteil, Lille, Lyon, Marseille, Nancy, Nantes, Paris
2022-09-01
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
845
Lyon, Vandœuvre-lès-Nancy, Lille, Clichy, Créteil, Nice, Paris, Strasbourg
2022-08-26
Recruiting
fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations
NCT04798131Schizophrenia, Hallucinations, Auditory, Hallucinations, Visual
University Hospital, Lille
Not applicable
84
Lille
2022-08-26
Active, closed
Biogen
Phase 2
416
Strasbourg, Toulouse, Montpellier, Saint-Herblain, Lille, Paris, Rouen
2022-08-24
Active, closed
Sanofi
Phase 2/3
1,856
Antony, Bordeaux, Clermont-Ferrand, Créteil, Lille, Nice, Reims, Rouen
2022-08-22
Active, closed
Janssen Research & Development, LLC
Phase 1
167
Lille, Paris, Strasbourg, Toulouse
2022-08-18
Recruiting
Regeneron Pharmaceuticals
Phase 1
317
Poitiers, Lille, Nantes, Angers, Montpellier, Paris, Villejuif, Créteil
2022-08-17
Recruiting
Bristol-Myers Squibb
Observational
1,700
Haguenau, Saint-Herblain, Lille, Amiens, Toulon, Poitiers, Montpellier
2022-08-16
Active, closed
Janssen Research & Development, LLC
Phase 3
418
La Tronche, Lille, Limoges, Marseille
2022-08-05
Recruiting
Perpetual Observational Study - Ventilator Associated Pneumonia
NCT05719259Ventilator Associated Pneumonia
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Observational
20,000
Chalon-sur-Saône, Dijon, Le Mans, Lille, Limoges, Tours
2022-08-03
Active, closed
Denali Therapeutics Inc.
Phase 2/3
65
Lille
2022-07-21
Active, closed
The TRICURE First in Human Trial
NCT05126030Tricuspid Regurgitation
TRiCares
Not applicable
20
Bordeaux, Bron, Créteil, Lille, Marseille, Rennes, Saint-Denis
2022-07-15
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Pierre-Bénite, Dijon, Besançon, Bordeaux, Lille, La Tronche, Poitiers, Rouen
2022-07-14
Active, closed
Novartis Pharmaceuticals
Phase 1/2
55
Lille, Marseille, Montpellier
2022-07-13
Active, closed
Genzyme, a Sanofi Company
Phase 4
17
Bordeaux, Brest, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes, Nice
2022-07-11
Recruiting
Pfizer
Phase 4
210
Lille, Villejuif
2022-07-05
Recruiting
Quanta Medical
Not applicable
50
Strasbourg, Lille
2022-07-01
Active, closed
Corcept Therapeutics
Phase 3
381
Lille, Montpellier, Nancy, Nice, Paris, Plérin
2022-06-29
Recruiting
Institut Claudius Regaud
Not applicable
120
Bordeaux, Caen, Clermont-Ferrand, Dijon, La Roche-sur-Yon, Lille, Limoges, Lyon
2022-06-23
Active, closed
Celgene
Phase 3
939
Argenteuil, La Roche-sur-Yon, Lille, Nancy, Nantes, Paris, Pessac, Rouen
2022-06-23
Active, closed
University Hospital, Lille
Observational
1,000
Lille
2022-06-16
Recruiting
Priothera SAS
Phase 3
366
Angers, Lille, Lyon, Nancy, Nantes, Paris, Strasbourg, Toulouse
2022-06-16
Active, closed
Genmab
Phase 2
264
Clermont, Rennes, Vandœuvre-lès-Nancy, Lille, Toulouse, Créteil, Nantes, Pierre-Bénite
2022-06-14
Active, closed
RECORDATI GROUP
Observational
206
Bordeaux, Bron, Grenoble, Le Kremlin-Bicêtre, Lille, Marseille, Nancy, Nantes
2022-06-13
Active, closed
Arcus Biosciences, Inc.
Phase 2
332
Bordeaux, Brest, Caen, Lille, Lyon, Marseille, Montpellier, Plérin
2022-06-10
Recruiting
University Hospital, Lille
Observational
40
Lille
2022-06-08
Active, closed
Evaluation of Regret in Kidney Transplantation
NCT05282381Renal Transplant Candidate for Right Kidney, Renal Transplant Candidate for Left Kidney
University Hospital, Lille
Observational
250
Lille
2022-06-03
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Amiens, Angers, Bordeaux, Lille, Lyon, Marseille, Paris, Rennes
2022-05-23
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Observational
1,350
Amiens, Angers, Besançon, Bobigny, Créteil, Dijon, Grenoble, Lille
2022-05-23
Recruiting
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
NCT05304377Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Cml
DrugELVN-001
Enliven Therapeutics
Phase 1
250
Amiens, Bordeaux, Lille, Limoges, Lyon, Pierre-Bénite
2022-05-22
Recruiting
University Hospital, Lille
Observational
20
Lille
2022-05-19
Recruiting
Evaluation of Safe Use of SECURIDRAP® SELFIA®
NCT05510401Disorientation, Cognitive Impairment, Behavior Disorders
Groupe Mulliez-Flory
Not applicable
108
Bailleul, Bully-les-Mines, Hazebrouck, Le Quesnoy, Lille, Limoux, Lyon, Rennes
2022-05-18
Active, closed
University Hospital, Bordeaux
Phase 1/2
80
Angers, Bordeaux, Lille, Lyon, Marseille, Nantes, Paris, Strasbourg
2022-05-17
Active, closed
IO Biotech
Phase 3
407
Besançon, Bordeaux, Boulogne-Billancourt, Dijon, La Tronche, Lille, Marseille, Nice
2022-05-17
Active, closed
University Hospital, Brest
Observational
160
Angers, Bordeaux, Bourg-en-Bresse, Brest, Caen, Lille, Limoges, Marseille
2022-05-12
Recruiting
The IMmunotherapy Pleural 5-ALA PDT
NCT04400539Mesotheliomas Pleural, Malignant Pleural Mesothelioma
DrugNivolumab
University Hospital, Lille
Phase 2
20
Lille
2022-05-09
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
30
Besançon, Bordeaux, Lille, Limoges, Lyon, Montpellier, Nice, Paris
2022-05-05
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Caen, Nancy, Bordeaux, Bron, Clermont-Ferrand, Lille, Nice, Poissy
2022-05-03
Recruiting
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
NCT05182164Soft Tissue Sarcoma Adult, Advanced Soft-tissue Sarcoma, Ewing Sarcoma, Osteosarcoma
DrugCabozantinib
Institut Bergonié
Phase 2
119
Bordeaux, Dijon, Lille, Lyon, Marseille, Paris, Saint-Herblain, Toulouse
2022-04-25
Recruiting
Bone Marrow Fat and Bariatric Surgery-Mediated Bone Loss
NCT05005039Bariatric Surgery in Postmenopausal Women
University Hospital, Lille
Observational
40
Lille
2022-04-20
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Bordeaux, Lille, Lyon, Marseille, Rennes, Saint-Herblain, Toulouse, Villejuif
2022-04-14
Active, closed
University Hospital, Lille
Observational
100
Caen, Lille
2022-04-13
Active, closed
Verastem, Inc.
Phase 1/2
153
Lille, Paris, Suresnes
2022-04-12
Recruiting
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
NCT04829175Stress Urinary Incontinence, Pelvic Organ Prolapse
Ethicon, Inc.
Observational
1,000
Lille
2022-04-11
Recruiting
University Hospital, Rouen
Phase 3
134
Amiens, Bobigny, Bordeaux, Brest, Créteil, Le Mans, Lille, Lyon
2022-04-10
Recruiting
University Hospital, Angers
Not applicable
1,045
Angers, Besançon, Bobigny, Dijon, La Roche-sur-Yon, La Tronche, Lille, Limoges
2022-04-07
Active, closed
Precise Procedural and PCI Plan (P4)
NCT05253677Coronary Artery Disease
CoreAalst BV
Not applicable
1,090
Lille
2022-04-01
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Bordeaux, Lille, Paris
2022-03-29
Active, closed
Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
NCT06910566Smoking Cessation, Nicotine Addiction, Nicotine Dependence, Smoking
Centre Oscar Lambret
Observational
100
Lille
2022-03-28
Recruiting
University Hospital, Angers
Not applicable
140
Besançon, Brest, Chambray-lès-Tours, Dijon, Lille, Limoges, Lyon, Montpellier
2022-03-25
Active, closed
Pfizer
Phase 3
854
Toulouse, Paris, Villejuif, Poitiers, Lille, Pierre-Bénite, Tours
2022-03-25
Recruiting
AbbVie
Phase 3
768
Marseille, Lille, Montpellier, Pessac, Paris, Avignon, Bron, Lyon
2022-03-25
Active, closed
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
NCT04769895Acute Graft Versus Host Disease in Intestine, Steroid Refractory GVHD
MaaT Pharma
Phase 3
66
Amiens, Angers, Caen, Grenoble, Lille, Marseille, Montpellier, Nice
2022-03-25
Active, closed
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
NCT05477576GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors
DrugsRYZ101·Octreotide·Lanreotide·Sunitinib
RayzeBio, Inc.
Phase 3
343
Clichy, Lille, Montpellier, Nantes, Vandœuvre-lès-Nancy, Villejuif
2022-03-24
Active, closed
GlaxoSmithKline
Phase 1
152
Dijon, Lille
2022-03-22
Recruiting
Amgen
Phase 3
60
Bron, Lille
2022-03-17
Active, closed
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT05333068Multivessel Coronary Artery Disease, Ischemia, Vulnerable Plaque, Coronary Artery Disease
Diagram B.V.
Not applicable
1,223
Lille, Nancy
2022-03-16
Active, closed
Centre Hospitalier Universitaire de Nice
Phase 3
72
Amiens, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Lille, Lyon, Marseille
2022-03-08
Recruiting
Quanta Medical
Not applicable
202
Agen, Périgueux, Tourcoing, Lille, Arcachon, Blendecques, Le Mans, Libourne
2022-03-08
Recruiting
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
NCT05246345Chronic Lymphocytic Leukemia, CLL, Progressive Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia
University Hospital, Clermont-Ferrand
Observational
50
Amiens, Besançon, Bobigny, Clermont-Ferrand, Grenoble, Lille, Lyon, Montpellier
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Avignon, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2022-03-04
Recruiting
Centre Oscar Lambret
Not applicable
651
Lille
2022-03-03
Active, closed
Chronic Pain and Hemophilia
NCT05202951Chronic Pain, Hemophilia
University Hospital, Clermont-Ferrand
Observational
350
Bordeaux, Caen, Chambéry, Clermont-Ferrand, Grenoble, Lille, Lyon, Nantes
2022-02-28
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma, Myelodysplastic Syndromes
DrugsAzoles·Gilteritinib·Azacitidine·Venetoclax
Sumitomo Pharma America, Inc.
Phase 1/2
606
Angers, Bobigny, Le Mans, Lille, Limoges, Lyon, Marseille, Nantes
2022-02-28
Recruiting
Metabolism, Circadian Rhythms and Ovarian Function
NCT05007834Chemotherapy-Induced Amenorrhea
University Hospital, Lille
Observational
50
Lille
2022-02-24
Recruiting
Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
NCT05116072Adenocarcinoma of the Pancreas, Adenocarcinoma of the Duodenum, Ampullary Adenocarcinoma
University Hospital, Lille
Phase 1/2
36
Lille
2022-02-20
Active, closed
AstraZeneca
Phase 3
791
Aix-en-Provence, Angers, Bobigny, Lille, Paris, Pau, Quimper, Saint-Grégoire
2022-02-18
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2
310
Nice, Dijon, Besançon, Brest, Toulouse, Lille, Paris, Saint-Herblain
2022-02-17
Active, closed
BIOlogics in Severe Nasal POlyposis SurvEy
NCT05228041Chronic Rhinosinusitis With Nasal Polyps
DrugsOmalizumab·Mepolizumab·Tezepelumab·Dupilumab
University Hospital, Lille
Observational
100
Lille
2022-02-10
Active, closed
Amgen
Phase 1/2
329
Dijon, Lille, Paris, Villejuif
2022-02-01
Active, closed
ADH1 and ADH2 Disease Monitoring Study (DMS)
NCT05227287Autosomal Dominant Hypocalcemia
Calcilytix Therapeutics, Inc., a BridgeBio company
Observational
95
Bron, Lyon, Lille, Le Kremlin-Bicêtre
2022-01-20
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
300
Brest, Lille, Montpellier, Paris, Strasbourg, Talence, Le Kremlin-Bicêtre
2022-01-20
Active, closed
Lille Study for Childhood Health Promotion
NCT05121090Overweight, Infant, Overweight and Obesity, Overweight, Childhood
University Hospital, Lille
Observational
460
Lille
2022-01-19
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
152
Bordeaux, Lille, Lyon, Paris, Poitiers, Reims, Rennes, Saint-Mandé
2022-01-19
Active, closed
Centre Leon Berard
Phase 2
58
Lyon, Bordeaux, Lille, Marseille, Nice, Poitiers, Reims, Rennes
2022-01-14
Recruiting
Observatory of the Lille Paediatric Allergy Unit
NCT06634992Child Allergy, IgE-Mediated Allergic Process, Food Allergy
Lille Catholic University
Observational
1,000
Lille
2022-01-01
Recruiting
Institut Curie
Not applicable
314
Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2021-12-28
Recruiting
Novartis Pharmaceuticals
Phase 1/2
34
Bordeaux, Lille, Paris, Poitiers
2021-12-27
Active, closed
Washington University School of Medicine
Phase 2/3
197
Toulouse, Lille, Paris, Bron, Rouen
2021-12-22
Recruiting
Occlutech International AB
Observational
255
Le Plessis-Robinson, Lille, Nantes
2021-12-20
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
71
Avignon, Bayonne, Besançon, Bordeaux, Corbeil-Essonnes, La Roche-sur-Yon, Lille, Limoges
2021-12-20
By invitation
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
NCT05041309Solid and Hematological Malignancies, Autoimmune Diseases
DrugsKITE-197·SPRX002·KITE-753·Tecartus
Kite, A Gilead Company
Observational
1,500
Lille, Montpellier, Paris, Pessac, Pierre-Bénite, Rennes
2021-12-15
Active, closed
Nantes University Hospital
Phase 2
75
Annecy, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Dijon, La Roche-sur-Yon, Lille
2021-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Limoges, Toulon, Caen, Clermont-Ferrand, Dijon, Gonesse, Grenoble, Lille
2021-12-13
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Amiens, Brest, Caen, Dijon, Lille, Lyon, Marseille, Neuilly-sur-Seine
2021-12-10
Not yet open
University Hospital, Caen
Not applicable
120
Amiens, Caen, Lille, Rouen
2021-12-10
Active, closed
NTLA-2002 in Adults With Hereditary Angioedema (HAE)
NCT05120830Hereditary Angioedema
Intellia Therapeutics
Phase 1/2
37
Grenoble, Lille, Paris
2021-12-10
Recruiting
Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.
NCT04573673Multiple Sclerosis, Lower Urinary Tract Symptoms
University Hospital, Lille
Not applicable
68
Lille
2021-12-01
Active, closed
Womed
Not applicable
160
Le Kremlin-Bicêtre, Lille, Marseille, Paris, Rennes
2021-11-29
Recruiting
Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma
NCT04749108Locally Advanced Malignant Neoplasm, Rectal Carcinoma
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2/3
1,075
Marseille, Besançon, Bordeaux, Montpellier, Vandœuvre-lès-Nancy, Nancy, Lille, Amiens
2021-11-26
Recruiting
University Hospital, Bordeaux
Observational
1,000
Caen, Corbeil-Essonnes, Dijon, La Réunion, La Rochelle, Le Creusot, Lille, Marseille
2021-11-24
Recruiting
Janssen Pharmaceutica N.V., Belgium
Observational
300
Lille, Montpellier, Nantes, Pierre-Bénite, Toulouse
2021-11-18
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Avignon, Bron, La Tronche, Le Mans, Lille, Marseille, Montpellier, Paris
2021-11-17
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 3
70
Marseille, Strasbourg, Bron, Lille, Le Kremlin-Bicêtre, Paris
2021-11-16
Recruiting
Trichoscopy and Systemic Scleroderma
NCT04804930Scleroderma, Systemic
University Hospital, Lille
Observational
200
Lille
2021-11-08
Active, closed
Amgen
Phase 3
303
Créteil, Dijon, Le Chesnay, Lille, Marseille, Nantes, Nice, Paris
2021-11-02
Recruiting
Centre Oscar Lambret
Observational
100
Lille
2021-11-02
Active, closed
Hoffmann-La Roche
Phase 3
478
Bayonne, Chambéry, Créteil, Lille, Marseille, Montpellier, Nantes, Nice
2021-10-27
Recruiting
Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema
NCT04763577Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
University Hospital, Grenoble
Observational
243
Grenoble, Lille, Paris, Rouen
2021-10-27
Active, closed
Camurus AB
Phase 3
332
Bordeaux, Chambray-lès-Tours, Dijon, Lille, Lyon, Nantes, Rennes, Strasbourg
2021-10-22
Active, closed
Immunotherapy in MSI/dMMR Tumors in Perioperative Setting.
NCT04795661Localized Resectable Tumor, MSI/dMMR
DrugPembrolizumab
Centre Leon Berard
Phase 2
240
Amiens, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille, Montpellier, Nice
2021-10-18
Active, closed
AstraZeneca
Phase 3
732
Bezannes, Bordeaux, Lille, Lyon, Montpellier, Plérin, Toulouse, Villejuif
2021-10-18
Active, closed
Myotonic Dystrophy - Vascular and Cognition
NCT04656210Myotonic Dystrophy 1, Diabetes, Carbohydrate Intolerance
University Hospital, Lille
Observational
85
Lille
2021-10-14
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Créteil, Lille, Limoges, Lyon, Nantes, Poitiers, Strasbourg, Toulouse
2021-10-14
Recruiting
Hospices Civils de Lyon
Not applicable
220
Amiens, Besançon, Bordeaux, Boulogne-Billancourt, Brest, Caen, Lille, Lyon
2021-10-14
Active, closed
Beeline Medicines Corporation
Phase 2
248
Pessac, Brest, Bordeaux, Caen, Lille, Marseille, Strasbourg
2021-10-11
Recruiting
University Hospital, Lille
Observational
226
Lille
2021-10-08
Recruiting
Lille Catholic University
Not applicable
150
Arras, Lens, Lille, Lomme, Rouen
2021-10-08
Recruiting
Pfizer
Phase 3
893
Limoges, Lille, Nantes, Paris, Pierre-Bénite, Poitiers, Toulouse
2021-10-04
Active, closed
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
39
Amiens, Bordeaux, Caen, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille
2021-09-30
Active, closed
Hoffmann-La Roche
Phase 3
217
Bordeaux, Lille, Lyon, Marseille, Rennes, Toulouse, Vantoux
2021-09-30
Recruiting
Study of an Environmental Risk Factor in Crohn's Disease
NCT04960826Inflammatory Bowel Diseases
University Hospital, Lille
Observational
100
Lille
2021-09-27
Active, closed
Study of INBRX-109 in Conventional Chondrosarcoma
NCT04950075Conventional Chondrosarcoma
DrugINBRX-109
Inhibrx Biosciences, Inc
Phase 2
206
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nice, Paris, Rennes
2021-09-23
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
333
Grenoble, Lille, Nice, Paris, Strasbourg, Villejuif
2021-09-22
Active, closed
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT04850105Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics
Observational
202
Lille, Nice, Nantes
2021-09-21
Recruiting
University Hospital, Strasbourg, France
Not applicable
400
Besançon, Dijon, Lille, Marseille, Montpellier, Nancy, Strasbourg, Toulouse
2021-09-20
Recruiting
BeOne Medicines
Phase 1/2
246
Lille, Nantes, Poitiers
2021-09-16
Recruiting
University Hospital, Lille
Observational
320
Lille
2021-09-15
Recruiting
Colibri Transcatheter Aortic Heart Valve System Study
NCT04029844Severe Aortic Stenosis
Colibri Heart Valve LLC
Not applicable
30
Lille, Massy, Toulouse
2021-09-15
Active, closed
Boston Scientific Corporation
Not applicable
155
Aix-en-Provence, Angers, Bordeaux, Grenoble, Lille, Lyon, Nice, Paris
2021-09-15
Recruiting
University Hospital, Bordeaux
Not applicable
253
Bordeaux, Grenoble, Lille, Limoges, Lyon, Marseille, Montpellier, Nancy
2021-09-13
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
DrugTacabrutideg
BeOne Medicines
Phase 1/2
689
Bordeaux, ClermontFerrand, Créteil, Lille, Lyon, Marseille, Montpellier, Paris
2021-09-13
Recruiting
fNIRS in Pediatric Hearing Aids
NCT04696835Hearing Loss
University Hospital, Lille
Not applicable
40
Lille
2021-09-09
Active, closed
Il-Yang Pharm. Co., Ltd.
Phase 2
43
Lille, Limoges, Lyon, Nantes, Paris, Poitiers, Rouen
2021-09-09
Active, closed
Albireo, an Ipsen Company
Phase 3
62
Bron, Lille, Paris
2021-09-03
Recruiting
University Hospital, Lille
Observational
550
Lille, Rouen
2021-09-01
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Bobigny, Cholet, Clermont-Ferrand, Créteil, Échirolles, Lille, Lyon, Nice
2021-08-25
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Lille, Nantes, Paris, Poitiers, Toulouse
2021-08-19
Active, closed
Inventiva Pharma
Phase 3
1,000
Lyon, Strasbourg, Marseille, Dijon, Besançon, Lille, Rennes, Grenoble
2021-08-19
Recruiting
Miltenyi Biomedicine GmbH
Phase 2
213
Créteil, Lille, Lyon, Marseille, Nantes, Pessac, Poitiers, Toulouse
2021-08-18
Recruiting
medac GmbH
Phase 3
210
Amiens, Besançon, Grenoble, Lille, Nantes, Nice, Pierre-Bénite, Toulouse
2021-08-16
Active, closed
HUYABIO International, LLC.
Phase 3
450
Besançon, Boulogne-Billancourt, Dijon, La Tronche, Lille, Marseille, Paris, Pierre-Bénite
2021-08-12
Active, closed
AstraZeneca
Phase 3
712
Amiens, Bayonne, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Nice
2021-08-05
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Bordeaux, Caen, Lille, Lyon, Marseille, Nantes, Nice, Paris
2021-08-04
Recruiting
ARCAGY/ GINECO GROUP
Phase 2
27
Angers, Besançon, Bordeaux, Dijon, Lille, Limoges, Lyon, Montpellier
2021-08-04
Active, closed
GLSMED Learning Health S.A.
Not applicable
533
Amiens, Clermont-Ferrand, Lille
2021-08-01
Recruiting
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer
NCT04811703Metastatic Ovarian Carcinoma, Peritoneal Carcinomatosis, Stage III Ovarian Cancer, Stage III Fallopian Tube Cancer
Hospices Civils de Lyon
Phase 1
15
Lille, Lyon, Pierre-Bénite
2021-07-30
Recruiting
Novartis Pharmaceuticals
Phase 3
98
Lille, Marseille, Montpellier, Paris
2021-07-28
Active, closed
Novartis Pharmaceuticals
Phase 3
208
Lille, Nantes, Nice, Paris, Toulouse
2021-07-27
Active, closed
University Hospital, Lille
Not applicable
320
Lille, Lyon, Nantes, Orléans, Paris, Poitiers, Vandœuvre-lès-Nancy
2021-07-23
Recruiting
Centre Leon Berard
Phase 2
36
Besançon, Bordeaux, Dijon, Lille, Lyon, Marseille, Montpellier, Nantes
2021-07-21
Active, closed
Boston Scientific Corporation
Not applicable
297
Grenoble, Lille, Nantes, Paris
2021-07-20
Recruiting
Valved Graft PMCF Study
NCT04754217Aortic Valve Disease, Ascending Aorta Abnormality, Aortic Dissection
Abbott Medical Devices
Observational
260
Besançon, Lille, Paris
2021-07-13
Recruiting
Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
NCT04927156Intracranial Aneurysm, Brain Arterial Disease, Acute Ischemic Stroke, Peripheral Vascular Diseases
Balt Extrusion
Observational
10,000
Angers, Bordeaux, La Tronche, Lille, Paris, Tours
2021-07-12
Active, closed
Ethicon, Inc.
Observational
198
Lille
2021-07-07
Recruiting
A Case Management Algorithm for Women Victims of Violence
NCT04953273Post-Traumatic Stress Disorder, Violence-Related Symptom
University Hospital, Lille
Not applicable
756
Amiens, Boulogne-sur-Mer, Caen, Creil, Lille, Rouen, Saint-Quentin, Valenciennes
2021-07-06
Recruiting
HighLife SAS
Not applicable
30
Lille, Nantes, Rennes, Toulouse
2021-07-01
Recruiting
Centre Francois Baclesse
Phase 2
72
Caen, Lille, Rouen
2021-06-30
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Marseille, Dijon, Toulouse, Lille, Poitiers, Paris
2021-06-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Chambray-lès-Tours, Avignon, Besançon, Bordeaux, Brest, Dijon, Lille, Lyon
2021-06-24
Recruiting
Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes
NCT04583800Diabetes Mellitus, Type 2, Heart Failure, Cognitive Decline
University Hospital, Lille
Observational
600
Lille
2021-06-22
Active, closed
University Hospital, Lille
Observational
108
Lille, Rouen
2021-06-22
By invitation
Philips Clinical & Medical Affairs Global
Not applicable
3,212
Lille, Nîmes
2021-06-17
Recruiting
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NCT04498767Gynecologic Cancer, Skin Cancer, Head and Neck Cancer, Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
200
Lille, Villejuif
2021-06-10
Recruiting
Influence of Cerebral Oedema in Intracerebral Haemorrhage
NCT04621357Stroke, Intra Cerebral Hemorrhage
University Hospital, Lille
Not applicable
500
Lille
2021-06-04
Active, closed
Daiichi Sankyo
Phase 2
155
Dijon, Lille, Lyon, Paris, Pierre-Bénite, Toulouse
2021-06-03
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
200
Gentilly, Lille, Nice, Paris, Rouen
2021-06-02
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
DrugsPosaconazole·Sonrotoclax·Azacitidine
BeOne Medicines
Phase 1/2
260
Lille, Nice, Paris
2021-05-24
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
96
Avignon, Besançon, Brest, Créteil, Dijon, Le Mans, Levallois-Perret, Lille
2021-05-21
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
252
Amiens, Besançon, Clichy, Créteil, Grenoble, Lille, Lyon, Montpellier
2021-05-21
Active, closed
Daiichi Sankyo
Phase 3
490
Besançon, Brest, Lille, Lyon, Marseille, Montpellier, Paris, Saint-Priest-en-Jarez
2021-05-21
Active, closed
Pfizer
Phase 3
599
Brest, Le Mans, Angers, Bayonne, Lille, Lyon, Paris, Pierre-Bénite
2021-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Nice, Pessac, Strasbourg, Brest, Toulouse, Lille, La Tronche, Saint-Herblain
2021-05-12
Active, closed
Incyte Corporation
Phase 3
899
Caen, Bordeau, Amiens, Bordeaux, La Tronche, Le Chesnay, Le Mans, Lille
2021-05-11
Recruiting
University Hospital, Lille
Observational
240
Lille
2021-05-06
Active, closed
Abbott Medical Devices
Observational
200
Bordeaux, Lille, Lyon, Rennes, Toulouse
2021-05-04
Recruiting
Erasmus Medical Center
Not applicable
600
Lille
2021-05-01
Active, closed
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
NCT04868877Non-Small Cell Lung Cancer Metastatic, Gastric Cancer, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
DrugsBispecific·Tagrisso·Osimertinib
Merus B.V.
Phase 1/2
194
Amiens, Bordeaux, Bron, Créteil, Lille, Marseille, Nantes, Paris
2021-04-28
Active, closed
Hoffmann-La Roche
Phase 3
557
Grenoble, Lille, Marseille, Montpellier, Nantes, Paris, Pessac, Rennes
2021-04-26
Recruiting
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
NCT03967834Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma, Perivascular Epithelioid Cell Neoplasms
Institut Claudius Regaud
Not applicable
400
Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Limoges, Lyon, Marseille
2021-04-26
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
NCT04752722Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
DrugPhase 2
enGene, Inc.
Phase 1/2
350
Angers, Bordeaux, Lille, Lyon, Paris, Rouen
2021-04-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Marseille, Besançon, Brest, Toulouse, Limoges, La Tronche, Orléans, Lille
2021-04-21
Active, closed
Assistance Publique Hopitaux De Marseille
Not applicable
140
Amiens, Angers, Bordeaux, Dijon, Grenoble, Lille, Lyon, Marseille
2021-04-16
Recruiting
Tendyne European Experience Registry
NCT04898335Mitral Regurgitation
LMU Klinikum
Observational
400
Bordeaux, Lille, Rennes, Toulouse
2021-04-15
Recruiting
Laboratory and Clinical Data in Antiphospholipid Patients
NCT04308564Antiphospholipid Syndrome
Central Hospital, Nancy, France
Observational
60
Lille, Nancy
2021-04-12
Active, closed
Economic Evaluation of Prostatic Urethral Lift
NCT04726748Benign Prostatic Hyperplasia
University Hospital, Bordeaux
Observational
1,360
Lille, Montpellier, Paris, Pierre-Bénite, Talence, Tours
2021-04-08
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Bordeaux, Paris, Lille, Vandœuvre-lès-Nancy, Politiers, Rouen, Nantes, Pessac
2021-04-08
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Angers, Clichy, Lille, Lyon, Nice, Paris, Pessac, Pierre-Bénite
2021-04-01
Active, closed
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
NCT03915678Solid Tumor, Adult, Pancreatic Cancer, Virus-associated Tumors, Non Small Cell Lung Cancer
Institut Bergonié
Phase 2
247
Bordeaux, Brest, Caen, Dijon, Lille, Marseille, Paris, Poitiers
2021-03-31
Recruiting
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
NCT04786262Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia
DrugZimislecel
Vertex Pharmaceuticals Incorporated
Phase 3
57
Lille, Strasbourg
2021-03-29
Recruiting
Monitoring the Weight Evolution Using a Connected Scale
NCT04639778Bariatric Surgery, Long Term Follow-Up, Weight Regain
University Hospital, Lille
Not applicable
390
Boulogne-sur-Mer, Lille
2021-03-25
Active, closed
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
NCT04620239Transitional Cell Cancer of Renal Pelvis and Ureter
Steba Biotech S.A.
Phase 3
89
Lille, Lyon
2021-03-22
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
La Roche-sur-Yon, Lille, Lyon, Nîmes, Paris, Pierre-Bénite, Rennes, Saint-Herblain
2021-03-18
Active, closed
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
NCT04591392Heart Septal Defect, Heart Septal Defects, Atrial, Heart Defects, Congenital, Cardiovascular Abnormalities
atHeart Medical
Not applicable
250
Bordeaux, Lille, Nantes, Paris, Toulouse
2021-03-12
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Bordeaux, Clermont-Ferrand, Pierre-Bénite, Brest, Nîmes, Mulhouse, Lille, Tours
2021-03-11
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
62
Bordeaux, Clermont-Ferrand, Créteil, Dijon, Lille, Montpellier, Nantes, Paris
2021-03-10
Active, closed
University Hospital, Bordeaux
Not applicable
500
Bordeaux, Brest, Lille, Paris, Strasbourg
2021-03-10
Rows per page Showing 501–1000 of 1282
Previous 1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 October 2026. https://priyalifescience.com/clinical-trials-france/city/lille?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,282 of those studies with a site in Lille.

How many clinical trials are recruiting in Lille?

711 of the 1,282 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 89 have not yet opened recruitment, 466 are active but closed to new participants, and 16 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.